Welcome to our dedicated page for Argan SEC filings (Ticker: AGX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Argan, Inc. SEC filings document the company’s operating results, material events and governance as a NYSE-listed construction services issuer. Recent 8-K filings report quarterly and fiscal financial results, cash dividends, share repurchase program actions, and engineering, procurement and construction contract developments involving Gemma Power Systems and power-generation projects.
Proxy materials cover board elections, executive compensation, equity awards, shareholder voting matters and related governance disclosures. The filings also identify Argan’s common stock registration and formal event reporting for capital allocation and project-backlog developments.
ARGAN INC director William F. Griffin Jr. reported two open-market sales of the company’s common stock held indirectly through the “William F Griffin Jr GRAT II dtd Oct 6, 2025.” On June 18, 2026, the GRAT sold 30,000 shares at an average price of $725.85 per share. On June 22, 2026, it sold another 20,000 shares at an average price of $760.43 per share. After these transactions, the reported indirect holding stands at 40,976 common shares.
AGX filing submits an amended notice of proposed sale of Common shares. The excerpt lists securities associated with Morgan Stanley Smith Barney LLC Executive Financial Services and multiple reported dispositions by Peter W. Getsinger on 04/02/2026, 04/29/2026, and 06/16/2026.
The filing shows prior private acquisition of 2,000 Common shares on 10/18/2020 and individual sale entries of 4,728 shares for $3,350,497.20, 3,000 shares for $1,885,071.30, and 2,581 shares for $1,426,606.36.
William F. Griffin reported the resale of 20,000 shares of Common stock via an exchange transaction on 06/22/2026. The filing also discloses prior sales of 50,000 shares on 06/12/2026 and 30,000 shares on 06/18/2026 with cash proceeds listed for each trade.
ARGAN INC Chief Financial Officer Joshua Scott Baugher reported option exercises and share sales in company stock. On June 17, 2026, he exercised a stock option awarded on April 16, 2024 to purchase 1,000 shares of common stock at a price of $61.22 per share using the net settle method. That same day, he sold 455 shares on the open market at $732.83 per share and 305 shares at $734 per share, resulting in total open-market sales of 760 shares.
Charles Schwab Corp. reported a Section 144 notice for proposed sales of common stock. The filing lists 30,000 shares as the securities to be sold and shows a prior sale of 50,000 shares on 06/12/2026 with an aggregate amount of $32,173,094.72. The notice records an issuer address at 3000 Schwab Way, Westlake, TX.
ARGAN INC director Karen Sweeney reported an open-market sale of company stock. On June 17, 2026, she sold 300 shares of Argan common stock at a price of $705 per share. After this transaction, she directly holds 1,548 shares of Argan common stock.
ARGAN INC director Peter W. Getsinger reported an option exercise followed by open-market sales of common stock. On June 15, 2026, he exercised a stock option to purchase 5,000 shares at $35.72 per share using the net settle method, resulting in 4,728 shares of common stock.
He then sold 4,728 shares on June 16, 2026 at an average price of $708.65 per share and 2,000 additional shares on June 17, 2026 at an average price of $699.00 per share. After these transactions, he directly owns 4,880 shares of common stock and 3,000 options to purchase common stock, and indirectly reports 133 shares held in a custody account for a child and 267 shares held in a children's trust.
Peter W. Getsinger filed a Form 144 proposing sales of Common stock. The notice lists an intended sale of 2,000 shares (exercise of options under a registered plan dated 04/01/2026) and reports actual sales in the past three months of 4,728, 3,000 and 2,581 shares on 06/16/2026, 04/29/2026 and 04/02/2026, respectively, with corresponding proceeds reported.
The transactions are reported through Morgan Stanley Smith Barney LLC as broker/dealer. The filing is a regulatory notice of proposed and recent dispositions; cash‑flow treatment is shown as cash for the exercise and specific proceeds are listed for the past sales.
AGX submitted a Form 144 notice reporting a proposed sale of 760 shares and related equity activity. The filing lists an option exercise for 455 shares on 06/17/2026, a restricted stock issuance of 305 shares on 04/17/2026, and a reported sale of 600 shares by Joshua Baugher on 04/16/2026 for $363,360.